European Commission approves Celltrion's Remsima IV liquid formulation
TIRmed Pharma partners with Bachem to advance production of atopic dermatitis therapy
Fondazione Telethon reports positive opinion for Waskyra marketing authorisation in Europe
Vascarta and CUNY report positive preclinical results in glioblastoma treatment
Cellipont Bioservices and Ernexa Therapeutics form cell therapy partnership
Hemogenyx Pharmaceuticals advances HG-CT-1 trial and opens paediatric recruitment
CStone announces Phase I CS2009 data at ESMO 2025
Merck KGaA to acquire JSR Life Sciences chromatography business to expand Protein A capabilities
Bristol Myers Squibb to acquire Orbital Therapeutics for USD1.5bn to expand cell therapy portfolio
Celltrion launches AVTOZMA IV in the United States following FDA approval
OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem